Med14 phosphorylation shapes genomic response to GLP-1 agonists
https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
Proceedings of the National Academy of Sciences, Volume 123, Number 10, March 2026.
ImportanceStable GLP-1 agonists like Exendin-4 and Ozempic have become a mainstay of treatment for type II diabetes; these peptides improve insulin secretion and beta cell viability in part through sustained activation of the cAMP-CREB pathway. …
